Cannabis and Heart Attack Risk
Cannabis raises acute heart attack risk; long-term cardiovascular safety in daily users remains unclear.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
Cannabis is not cardioprotective. THC temporarily raises heart rate and blood pressure, creating a measurable (though small) spike in heart attack risk in the first hour after use. Heavy daily smokers with existing heart disease face the most hazard. The gap between 'cannabis is safe' marketing and the actual evidence is real. Occasional use in otherwise healthy people carries lower absolute risk, but it is not zero.
Not Medical Advice
This article is not medical advice. It is a plain-language summary of published research. If you have known heart disease, high blood pressure, a family history of early cardiac events, or are recovering from a heart attack or stroke, talk to a cardiologist before using cannabis in any form. If you are using cannabis and develop chest pain, shortness of breath, rapid or irregular heartbeat, or one-sided weakness, call emergency services immediately.
Plain-Language Summary
Cannabis — particularly THC — raises heart rate and changes blood pressure for an hour or two after use. In healthy young people occasional use poses small absolute risk. In people with existing coronary artery disease or in those who smoke cannabis daily, the evidence points to a measurable increase in heart attack risk Weak / limited.
The clearest signals come from three groups: (1) users in the first hour after smoking, (2) daily smokers, and (3) people under 50 who have a heart attack at an age when it is otherwise rare [1][2][3]. Cannabis's cardiovascular risk is smaller than cigarette smoking's, but larger than most people realize. The gap between marketing claims of safety and the actual evidence is substantial.
What We Know: Acute Risk
Heart attack risk in the first hour: A landmark 2001 case-crossover study of myocardial infarction (MI) survivors found the risk of MI rose approximately 4.8-fold in the 60 minutes after cannabis smoking, compared to baseline [1] Weak / limited. This mirrors the acute coronary trigger effect of other stressors (heavy exertion, emotional upset, cocaine use). After the first hour, risk appears to return toward baseline.
Daily use and long-term MI risk: A 2024 analysis of Behavioral Risk Factor Surveillance System (BRFSS) data covering over 430,000 adults found daily cannabis users had 25% higher adjusted odds of myocardial infarction and 42% higher adjusted odds of stroke compared to non-users [2] Weak / limited. This association persisted after adjustment for age, sex, smoking status, and other cardiovascular risk factors.
Stroke risk: Separate Cannabis and Stroke Risk literature confirms similar population-level associations, with some studies showing elevated risk in young adults particularly Weak / limited.
What Might Work (Very Limited Evidence)
CBD and acute blood pressure: A small 2017 randomized crossover study (n=9 healthy male volunteers) found a single 600 mg oral dose of CBD reduced resting systolic blood pressure by approximately 6 mmHg [5] Weak / limited. This is a single acute dose in a tiny, healthy sample; it does not support CBD as a blood pressure therapeutic. Long-term safety and efficacy are unstudied.
CBD and stress-induced cardiovascular response: Preclinical and small human studies suggest CBD may blunt sympathetic activation during acute stress, but clinical cardiovascular outcomes have not been tested Weak / limited.
These findings are interesting for basic science but do not justify cannabis or CBD as a cardiovascular intervention.
What Doesn't Work / Folklore
- 'Cannabis lowers blood pressure' — Acutely, THC typically raises heart rate and can cause orthostatic (postural) blood pressure drops, not sustained reductions. Some chronic heavy users show modestly lower resting blood pressure in cross-sectional studies, but this is not a treatment effect and does not translate to cardiovascular benefit Disputed.
- 'Edibles are heart-safe because there's no smoke' — Edibles avoid combustion byproducts, but THC's effects on Cannabis and Heart Rate, vascular tone, and platelet aggregation do not depend on smoking. Smoking adds additional combustion-related injury; it is not the entire risk source Weak / limited.
- 'Indica strains are calming, so they're safer for the heart' — The indica vs sativa distinction does not predict cardiovascular effects. This is marketing folklore unsupported by controlled research No data.
- 'It's natural, so it's safe for the heart' — Naturalness does not confer safety. Tobacco, hemlock, and nicotine are all natural and all cardiotoxic.
What We Don't Know
- Dose-response thresholds: We lack well-defined thresholds for how much THC, how often, before cardiovascular risk rises meaningfully. Most epidemiology uses binary (any use vs none) or frequency (daily vs not) categories, not THC dose per occasion.
- Route of administration (detailed): Most large cohort studies do not distinguish smoked vs vaporized vs oral cannabis. Smoked cannabis involves combustion byproducts similar to tobacco; Cannabis Vaporization and Respiratory Effects addresses lung safety but long-term cardiac outcomes of vaping are essentially unstudied Weak / limited. Oral cannabis avoids combustion but has slower, longer-acting effects and little cardiovascular outcome data No data.
- High-potency concentrates: Modern extracts and distillates deliver THC doses (50–90% THC) far exceeding flower use in the 1970s–90s epidemiologic data. Cardiac effects of sustained high-dose THC are essentially unstudied No data.
- CBD-only products: No acute MI signal has been observed, but long-term cardiovascular outcomes in CBD-only users are not well characterized No data.
- Polypharmacy interactions: Co-use with stimulants (cocaine, amphetamines, pseudoephedrine, high-dose caffeine) likely compounds acute coronary risk, but specific quantification is poor. See Cannabis and Polypharmacy Risks.
- Protective mechanisms in some subgroups: Observational data cannot rule out that cannabis users with lower cardiovascular risk at baseline self-select into use, confounding the associations.
Comparison With Other Cardiac Risk Factors
For context, cannabis ranks among cardiac risk factors as follows:
| Risk Factor | Estimated Acute or Long-term MI Risk Increase | Evidence Quality |
|---|---|---|
| Cigarette smoking (heavy) | 2–4× chronic; 3–5× acute | Strong |
| Cocaine use (acute) | ~24× in first hour | Strong |
| Cannabis use (acute, first hour) | ~4.8× | Weak |
| Daily cannabis use | 25% higher odds (BRFSS 2024) | Weak |
| Untreated hypertension | 2–3× depending on severity | Strong |
| Untreated diabetes | 2–4× | Strong |
| Elevated LDL cholesterol | 1.5–3× depending on level | Strong |
| Sedentary lifestyle | 1.5–2× | Strong |
| Obesity | 1.2–2× depending on severity | Strong |
The honest framing: Cannabis is a cardiovascular risk factor, not the dominant one for most healthy people—unless you are a daily smoker with pre-existing heart disease, in which case it compounds meaningfully.
Specific Risks to Know
- Acute heart attack in the first hour: Risk rises 4.8× after smoking, per the landmark 2001 study [1]. This effect is largest in people with pre-existing coronary disease Weak / limited.
- Daily use and MI/stroke: A 2024 BRFSS analysis (n>430,000 adults) found daily cannabis use associated with 25% higher odds of MI and 42% higher odds of stroke after adjustment for age, sex, smoking, and other factors [2] Weak / limited.
- Young adults with MI: Multiple studies link cannabis use to myocardial infarction in adults under 50, an age at which MI is uncommon. A 2017 analysis of national inpatient data found cannabis-related admissions for acute MI in young adults [6] Weak / limited.
- Arrhythmias: Case reports and some observational cohort data associate cannabis with new-onset atrial fibrillation and ventricular arrhythmias Weak / limited. Mechanisms may include sympathomimetic effects and direct cardiac electrophysiology changes.
- Cannabis arteritis and peripheral vascular disease: Rare cases of Buerger-like disease (cannabis arteritis) with peripheral vascular compromise have been reported in heavy cannabis smokers, possibly from chronic vasospasm or endothelial injury Weak / limited.
- Post-acute coronary syndrome outcomes: Limited data suggest cannabis use after acute MI or unstable angina is associated with worse clinical trajectories, though causality is difficult to establish Weak / limited.
Practical Guidance
If you are otherwise healthy, young, and use cannabis occasionally: Absolute risk increase is small. However, avoid cannabis use during periods of high physical exertion, emotional stress, or acute illness, when baseline coronary risk is elevated.
If you have known coronary disease, prior MI, uncontrolled hypertension, or are over 50 with multiple cardiovascular risk factors: The calculus is different. Discuss cannabis use with your cardiologist. The acute 4–5× spike in MI risk in the first hour may outweigh any perceived benefit. If you choose to use cannabis, do so only when you are at rest, well-hydrated, and in a safe environment, and preferably not with other cardiac stressors.
If you smoke cannabis daily: Current data suggest this pattern carries the highest risk signal in the literature. If you cannot stop, reduce frequency if possible. Smoked cannabis adds combustion byproducts; switching to oral or vaporized routes may lower (though not eliminate) cardiovascular burden, but long-term data on these routes are limited.
In all cases: If you experience chest pain, shortness of breath, palpitations, lightheadedness, or one-sided weakness while using or shortly after using cannabis, seek immediate emergency care.
What the Evidence Does Not Show
- That cannabis is cardioprotective in any population No data.
- That CBD or any other cannabinoid prevents or treats heart disease in humans No data.
- That 'natural' cannabis is safer than pharmaceutical cardiovascular medications No data.
- That occasional low-dose use in the absence of risk factors causes clinically significant harm No data; only that absolute risk is measurably higher than zero.
- That indica strains are more or less cardiotoxic than sativa strains No data.
The National Academies of Sciences, Engineering, and Medicine 2017 comprehensive review concluded: "There is substantial evidence that cannabis smoking is associated with increased symptoms of chronic bronchitis and is associated with a higher likelihood of an asthma diagnosis in frequent users." On cardiovascular effects specifically, they noted limited evidence for cannabis's role in adverse cardiac events but acknowledged the mechanistic plausibility of THC-driven acute coronary triggers [7].
Sources
- Peer-reviewed Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–2809.
- Peer-reviewed Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. Journal of the American Heart Association. 2024;13(1):e030178.
- Peer-reviewed DeFilippis EM, Bajaj NS, Singh A, et al. Marijuana use in patients with cardiovascular disease: JACC review topic of the week. Journal of the American College of Cardiology. 2020;75(3):320–332.
- Peer-reviewed Pacher P, Steffens S, Haskó G, Schindler TH, Kunos G. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nature Reviews Cardiology. 2018;15(3):151–166.
- Peer-reviewed Jadoon KA, Tan GD, O'Sullivan SE. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight. 2017;2(12):e93760.
- Peer-reviewed Desai R, Patel U, Sharma S, et al. Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States. Cureus. 2017;9(11):e1816.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Heart Rate — What cannabis actually does to your pulse, why it happens, and when an elevated heart rate...
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis and Stroke Risk — Cannabis use is associated with elevated stroke risk, especially in younger adults and wit...
- Cannabis and Stroke Risk in Young Adults — What research shows about cannabis use and stroke risk in younger populations.
- Cannabis Vaporization and Respiratory Effects — What vaporization does and doesn't do for respiratory health, backed by evidence.